Literature DB >> 29351872

Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old.

Jiri M G van Bergen1, Xu Li2, Frances C Quevenco3, Anton F Gietl4, Valerie Treyer5, Sandra E Leh6, Rafael Meyer4, Alfred Buck7, Philipp A Kaufmann7, Roger M Nitsch4, Peter C M van Zijl2, Christoph Hock4, Paul G Unschuld4.   

Abstract

The aging brain is characterized by an increased presence of neurodegenerative and vascular pathologies. However, there is substantial variation regarding the relationship between an individual's pathological burden and resulting cognitive impairment. To identify correlates of preserved cognitive functioning at highest age, the relationship between β-amyloid plaque load, presence of small vessel cerebrovascular disease (SVCD), iron-burden, and brain atrophy was investigated. Eighty cognitively unimpaired participants (44 oldest-old, aged 85-96 years; 36 younger-old, aged 55-80 years) were scanned by integrated positron emission tomography-magnetic resonance imaging for assessing beta regional amyloid plaque load (18F-flutemetamol), white matter hyperintensities as an indicator of SVCD (fluid-attenuated inversion recovery-magnetic resonance imaging), and iron load (quantitative susceptibility mapping). For the oldest-old group, lower cortical volume, increased β-amyloid plaque load, prevalence of SVCD, and lower cognitive performance in the normal range were found. However, compared to normal-old, cortical iron burden was lower in the oldest-old. Moreover, only in the oldest-old, entorhinal cortex volume positively correlated with β-amyloid plaque load. Our data thus indicate that the co-occurrence of aging-associated neuropathologies with reduced quantitative susceptibility mapping measures of cortical iron load constitutes a lower vulnerability to cognitive loss.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOE; Beta-amyloid; Cognitive reserve; Iron; MRI; Maintenance; Oldest-old; PET; QSM

Mesh:

Substances:

Year:  2017        PMID: 29351872      PMCID: PMC5820223          DOI: 10.1016/j.neurobiolaging.2017.12.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  52 in total

Review 1.  Memory aging and brain maintenance.

Authors:  Lars Nyberg; Martin Lövdén; Katrine Riklund; Ulman Lindenberger; Lars Bäckman
Journal:  Trends Cogn Sci       Date:  2012-05       Impact factor: 20.229

2.  MR evaluation of age-related increase of brain iron in young adult and older normal males.

Authors:  G Bartzokis; M Beckson; D B Hance; P Marx; J A Foster; S R Marder
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

3.  Early marker for Alzheimer's disease: the atrophic hippocampus.

Authors:  M J de Leon; A E George; L A Stylopoulos; G Smith; D C Miller
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

4.  18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

Authors:  Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; Eric Triau; Steen Hasselbalch; Ian Law; Allan Andersen; Alex Korner; Lennart Minthon; Gaëtan Garraux; Natalie Nelissen; Guy Bormans; Chris Buckley; Rikard Owenius; Lennart Thurfjell; Gill Farrar; David J Brooks
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

5.  Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease.

Authors:  Michael M Zeineh; Yuanxin Chen; Hagen H Kitzler; Robert Hammond; Hannes Vogel; Brian K Rutt
Journal:  Neurobiol Aging       Date:  2015-06-06       Impact factor: 4.673

6.  Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease.

Authors:  V Garibotto; B Borroni; S Sorbi; S F Cappa; A Padovani; D Perani
Journal:  Neurol Sci       Date:  2011-12-16       Impact factor: 3.307

7.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

8.  Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.

Authors:  Issel Anne L Lim; Andreia V Faria; Xu Li; Johnny T C Hsu; Raag D Airan; Susumu Mori; Peter C M van Zijl
Journal:  Neuroimage       Date:  2013-06-12       Impact factor: 6.556

9.  Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

Authors:  J M G van Bergen; X Li; J Hua; S J Schreiner; S C Steininger; F C Quevenco; M Wyss; A F Gietl; V Treyer; S E Leh; F Buck; R M Nitsch; K P Pruessmann; P C M van Zijl; C Hock; P G Unschuld
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

Review 10.  Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration.

Authors:  Hjalte Holm Andersen; Kasper Bendix Johnsen; Torben Moos
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

View more
  8 in total

1.  Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline.

Authors:  Jun Hua; SeungWook Lee; Nicholas I S Blair; Michael Wyss; Jiri M G van Bergen; Simon J Schreiner; Sonja M Kagerer; Sandra E Leh; Anton F Gietl; Valerie Treyer; Alfred Buck; Roger M Nitsch; Klaas P Pruessmann; Hanzhang Lu; Peter C M Van Zijl; Marilyn Albert; Christoph Hock; Paul G Unschuld
Journal:  Neurobiol Aging       Date:  2019-01-10       Impact factor: 4.673

2.  Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span.

Authors:  Suzanne L Baker; Theresa M Harrison; Anne Maass; Renaud La Joie; William J Jagust
Journal:  J Nucl Med       Date:  2019-03-15       Impact factor: 10.057

3.  Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age.

Authors:  J M G van Bergen; X Li; F C Quevenco; A F Gietl; V Treyer; R Meyer; A Buck; P A Kaufmann; R M Nitsch; P C M van Zijl; C Hock; P G Unschuld
Journal:  Neuroimage       Date:  2018-03-13       Impact factor: 6.556

4.  Background field removal for susceptibility mapping of human brain with large susceptibility variations.

Authors:  Jinsheng Fang; Lijun Bao; Xu Li; Peter C M van Zijl; Zhong Chen
Journal:  Magn Reson Med       Date:  2018-10-09       Impact factor: 4.668

Review 5.  Neuroimaging in the Oldest-Old: A Review of the Literature.

Authors:  Davis C Woodworth; Kiana A Scambray; María M Corrada; Claudia H Kawas; S Ahmad Sajjadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Low Subicular Volume as an Indicator of Dementia-Risk Susceptibility in Old Age.

Authors:  Sonja M Kagerer; Clemens Schroeder; Jiri M G van Bergen; Simon J Schreiner; Rafael Meyer; Stefanie C Steininger; Laetitia Vionnet; Anton F Gietl; Valerie Treyer; Alfred Buck; Klaas P Pruessmann; Christoph Hock; Paul G Unschuld
Journal:  Front Aging Neurosci       Date:  2022-03-03       Impact factor: 5.750

7.  APOE4 moderates effects of cortical iron on synchronized default mode network activity in cognitively healthy old-aged adults.

Authors:  Sonja M Kagerer; Jiri M G van Bergen; Xu Li; Frances C Quevenco; Anton F Gietl; Sandro Studer; Valerie Treyer; Rafael Meyer; Philipp A Kaufmann; Roger M Nitsch; Peter C M van Zijl; Christoph Hock; Paul G Unschuld
Journal:  Alzheimers Dement (Amst)       Date:  2020-02-07

8.  Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4.

Authors:  Frances C Quevenco; Jiri M van Bergen; Valerie Treyer; Sandro T Studer; Sonja M Kagerer; Rafael Meyer; Anton F Gietl; Philipp A Kaufmann; Roger M Nitsch; Christoph Hock; Paul G Unschuld
Journal:  Front Aging Neurosci       Date:  2020-03-09       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.